-
Featured
YAP1 Oncogene Synergizes with HPV to Promote Cervical Cancer
Researchers have provided in vitro and in vivo evidence that the YAP1 oncogene can induce cervical cancer regardless of HPV infection. Further, the synergism between HPV and YAP1 significantly accelerates the development of cervical cancer and HPV vaccination remains vitally important.
-
Featured
Minimally Invasive Surgery Linked to Shorter Survival in Early-Stage Cervical Cancer
Among women with early-stage cervical cancer who undergo radical hysterectomy, survival after minimally invasive surgery is significantly shorter than after open surgery, according to the largest-ever investigation of this question.
-
Featured
Combination Immunotherapy May Be the Best Treatment for Certain Uterine Cancers
Mass General researchers evaluated patients with six uterine cancer subtypes to identify those with the most potential for immunotherapy treatment.
-
Developing Precision Therapies for Ovarian Cancer
Researchers are working to develop next-generation tailored treatment protocols for ovarian cancer utilizing precision medicine techniques.
-
Review: Prophylactic Surgery for Women at Risk of Hereditary Ovarian or Endometrial Cancer
In women who have certain hereditary cancer mutations, prophylactic surgery can greatly reduce the risk of ovarian and endometrial cancer.
-
Risk of Death After Cytoreduction of Advanced Ovarian Cancer Differs by Age
Gynecologic oncologists suggest neoadjuvant chemotherapy and interval cytoreduction for older women with advanced ovarian cancer.
Gynecologic Oncology contributors
-
Cheng Wang, PhD
Associate Investigator, Vincent Center for Reproductive Biology, Associate Professor of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School
Recent Article
YAP1 May Be a Treatment Target for Certain Types of Female Subfertility -
Eric L. Eisenhauer, MD
Chief, Division of Gynecologic Oncology, Massachusetts General Hospital
Recent Article
Review: Prophylactic Surgery for Women at Risk of Hereditary Ovarian or Endometrial Cancer -
Marcela G. del Carmen, MD
Chief Medical Officer, Massachusetts General Physicians Organization, Gynecologic Oncologist, Center for Gynecologic Oncology
Recent Article
Editorial: It's Time to Study "Hospital at Home" After Surgery
-
Mary E. Sabatini, MD, PhD
Medical Director, Clinic for Reproductive Health and Cancer, Medical Director, Third Party Reproduction
Recent Article
The Müllerian Inhibiting Substance: Changing the Fertility Landscape for Young Women with Cancer
-
Whitfield B. Growdon, MD
Center for Gynecologic Oncology
Recent Article
Developing Precision Therapies for Ovarian Cancer
Mass General Cancer Center
An integral part of one of the world’s most distinguished academic medical centers, the Massachusetts General Hospital Cancer Center is among the leading cancer care providers in the United States.
